Cargando…
In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson’s disease
See Gratwicke and Foltynie (doi:10.1093/brain/awx333) for a scientific commentary on this article. Cognitive impairments are a prevalent and disabling non-motor complication of Parkinson’s disease, but with variable expression and progression. The onset of serious cognitive decline occurs alongside...
Autores principales: | Ray, Nicola J, Bradburn, Steven, Murgatroyd, Christopher, Toseeb, Umar, Mir, Pablo, Kountouriotis, George K, Teipel, Stefan J, Grothe, Michel J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837422/ https://www.ncbi.nlm.nih.gov/pubmed/29228203 http://dx.doi.org/10.1093/brain/awx310 |
Ejemplares similares
-
Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease
por: Wilson, Joanna, et al.
Publicado: (2020) -
Cholinergic basal forebrain atrophy in Parkinson's disease with freezing of gait
por: Gan, Caiting, et al.
Publicado: (2023) -
Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease
por: Teipel, Stefan J., et al.
Publicado: (2020) -
Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD)
por: Scheef, Lukas, et al.
Publicado: (2018) -
Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson’s disease
por: Ray, Nicola J, et al.
Publicado: (2022)